{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-041375","form_type":"8-K","ticker":"UTHR","cik":"0001082554","company_name":"UNITED THERAPEUTICS Corp","filed_at":"2022-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:59.666578+00:00","generated_at":"2026-06-26T10:13:12.744998+00:00","sec_items":["1.01","1.02","2.03","9.01"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"United Therapeutics enters $2B credit agreement, draws $800M to refinance existing debt","bullets":["New $2B unsecured revolving credit facility with $1.2B Tranche A and $800M Tranche B; can be increased by up to $500M.","Borrowed $800M at closing to repay outstanding indebtedness under 2018 credit agreement; no penalties for early termination.","Maturity five years from March 31, 2022, with two possible one-year extensions at borrower's request.","Interest at Adjusted Term SOFR or base rate plus margin tied to leverage ratio; covenant limits total debt/EBITDA to 3.00x (3.50x after acquisitions).","Financial covenants also require interest coverage ratio >= 3.00x; customary events of default and change of control clause."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-041375","json":"https://secwatch.observer/filing/0001104659-22-041375.json","markdown":"https://secwatch.observer/filing/0001104659-22-041375.md","text":"https://secwatch.observer/filing/0001104659-22-041375.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1082554/000110465922041375/0001104659-22-041375-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1082554/000110465922041375/tm2211000d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-26T10:13:12.744998+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}